Sodium metaarsenite (Komipharm)

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug NameSodium metaarsenite (Komipharm)
Drug Alias NamePANAPHIXKominoxKML-001PAX-1
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGene expression modulatorsSignal transduction pathway modulatorsTelomerase inhibitors
TargetsTelomerase
Therapy Area/IndicationsSmall Cell Lung CarcinomaCarcinoma, Non-Small-Cell Lung
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesKomipharm
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUniversity Of Maryland, Baltimore
Active IndicationsN/A
Inactive IndicationsSmall Cell Lung CarcinomaCarcinoma, Non-Small-Cell Lung

Other Information

ATC CodeN/A
Related LinksN/A